Stereotactic ablative radiotherapy (SABR) will be available as a treatment option through routine commissioning for hepatocellular carcinoma in adults within the criteria set out in this document.

SABR will be available as a treatment option through routine commissioning for patients (all ages) with controlled primary cancer presenting with up to three extracranial metachronous oligometastases which manifest after a disease-free interval following primary treatment of at least 6 months, in line with the criteria set out in this document.

NHS England will commission temozolomide as adjuvant treatment for people with newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (Adults) in accordance with the criteria outlined in this document.

This document describes a collective commitment made to establish a new learning healthcare system for radiotherapy in England.

The aim of this research by White et al (2011) was to explore factors that influence the identification of treatment-induced female sexual “difficulties” in routine oncology follow-up after radical pelvic radiotherapy.

NHS England will not routinely commission 18F-FDG-PET CT as part of radical radiotherapy treatment planning for oesophageal cancer in accordance with the criteria outlined in this document.

In creating this policy NHS England has reviewed this clinical condition and the options for its treatment. It has considered the place of this treatment in current clinical practice, whether scientific research has shown the treatment to be of benefit to patients, (including how any benefit is balanced against possible risks) and whether its use represents the best use of NHS resources.

NHS England will commission stereotactic radiosurgery (SRS) or stereotactic radiotherapy (SRT) for palliative treatment of patients with primary non-germ cell pineal region tumours in accordance with the criteria set out in this document.

NHS England will commission stereotactic radiosurgery (SRS) or stereotactic radiotherapy (SRT) for children with ependymoma in accordance with the criteria set out in this document.

This policy document outlines the arrangements for funding of Stereotactic radiosurgery and radiotherapy for the population in England.

This policy document outlines the arrangements for funding of the hypofractionated external beam radiotherapy treatment for the population in England.